November 11, 2008
Azopharma Unveils New UK Laboratory
and EU plans
HOLLYWOOD, Fla. – Azopharma Product Development GroupTM is pleased to announce its entrance into the European market with the addition of new laboratory facilities and office space located in Welwyn Garden City, UK. The new facility will provide analytical, QP release testing, preformulation and formulation development services to the European market.
Mr. Phil Meeks, CEO of Azopharma Product Development Group says, “This is a very exciting time for Azopharma with our first venture outside the USA. Our vision for the new laboratory is to provide key product development services to our many clients in Europe. We see this facility as the first step in bringing our complete service offerings to the region.” Read More